PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Recruiting
- Conditions
- Severe Infection
- Interventions
- Other: Description of severe infection
- Registration Number
- NCT06185920
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
- PHAGEinLYON Clinic cohort study information notice provided to the patient
Exclusion Criteria
- Opposition of trial participant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with severe infection. Description of severe infection Patients with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
- Primary Outcome Measures
Name Time Method Rate of each type of severe infection through study completion (5years) Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon
🇫🇷Lyon, France